FLEX November 2023
2292 COSTANTINO ET AL .
TABLE 1
(Continued)
SLN identification (%)
SLNB positive rate (%)
RRR (%)
Study
N (male) Age (range)
Criteria for high risk
SLNB technique
FU (months)
Klode et al. 53
19 (NA) NA
Tumor thickness >4.0 mm
SPECT/CT + Gamma probe
17/19 (89%)
0/17 (0%)
0 /17
NA
(0%)
Krediet et al. 54 8 (7)
Median 68.5 (range 66 – 83)
At least three of: tumor diameter ≥ 20 mm; specific tumor site; recurrent tumor;
Planar lymphoscintigraphy + Gamma probe + Blue dye
8/8 (100%)
0/8 (0%)
3/8 (38%) NA
immunosuppression; moderate or poor differentiation; and tumor thickness ≥ 4 mm or Clark Level ≥ 4 Deep dermis infiltration; poor differentiation; tumor diameter ≥ 10 mm At least one of: tumor size >2 cm; invasion into subcutaneous fat (Clark level 5) or depth of invasion >5 mm; poor differentiation; PNI; ALI; recurrent tumor; tumor specific location; immunosuppression; site of a scar Specific tumor site; tumor size >2 cm; depth of invasion >4 mm; moderate or poor differentiation; PNI; recurrent tumors AreaL ≥ 20 mm; area M ≥ 10 mm; areaH ≥ 6 mm; poorly defined borders; recurrent tumor; immunosuppression; prior RT; moderate or poor differentiation; Clark Level ≥ 4; PNI; ALI At least 1 risk factor: size >10 mm on the head; size >6 mm on the face; poorly defined borders; recurrent lesion; immunosuppression; site of prior RT or chronic inflammatory process; rapid growth
Michl et al. 55
5 (3)
Median 72 (range 54 – 79)
Planar lymphoscintigraphy + Gamma probe + Blue dye Planar lymphoscintigraphy + Gamma probe + Blue dye
5/5 (100%)
0/5 (0%)
0/5 (0%) NA
104 (90) Mean 65 (range 27 – 90)
Mooney et al. 56
99/105 (94%)
10/99 (10%)
5/89 (6%) Mean 26.2 (range 1 – 60)
11 (NA) Median 75 (range 59 – 90)
Planar lymphoscintigraphy + Gamma probe + Blue dye
11/11 (100%)
1/11 (9%)
2/10
Median24 (range 2 – 38)
Rastrelli et al. 57
(20%)
33 (NA) NA
Planar lymphoscintigraphy + Gamma probe
33/33 (100%)
0/33 (0%)
0/33 (0%) NA
Samsanavic ˇ ius et al. 58
5 (3)
Median 72 (range 47 – 77)
Takahashi et al. 59
Planar lymphoscintigraphy + Gamma probe
5/5 (100%)
0/5 (0%)
0/33 (0%) Median 37 (range 31 – 47)
10970347, 2022, 10, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/hed.27121 by Mount Sinai Health System Icah, Wiley Online Library on [02/08/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
Made with FlippingBook - Online catalogs